OUAGADOUGOU, The Society of Obstetrician Gynecologists of Burkina (SOGOB), in partnership with Ferring laboratories, initiated discussions on Saturday about a new molecule called thermostable carbetocin, aimed at preventing postpartum hemorrhage and reducing maternal mortality during childbirth.
According to Burkina Information Agency, postpartum hemorrhage remains the leading cause of death among women after childbirth, requiring urgent attention and action from health stakeholders, particularly obstetrician-gynecologists. To address this issue, SOGOB organized a meeting on Saturday, June 15, 2024, in Ouagadougou to strengthen the capacities of its members, such as midwives and other health actors, on the introduction of thermostable carbetocin in the health system.
Gynecologist Professor Jean Lankoandé, during a national restitution workshop on the pilot study of the management of postpartum hemorrhage with thermostable carbetocin in Burkina Faso, specified that the discussions would focus on cases of postpartum hemorrhage. “Today we gathered for post-graduate education. We want to introduce a new molecule called carbetocin which has proven itself worldwide in the prevention of postpartum hemorrhage,” explained Professor Jean Lankoandé. According to him, the aim is to equip gynecologists, midwives, gynecology students, and nurses to use carbetocin in a practical way.
Dr. Mousa Dadjoari, from the Directorate of Health and Family, noted that postpartum hemorrhage is the leading cause of maternal mortality in the world and in Burkina Faso. “We know that carbetocin is a molecule of the future for our country,” he maintained. Obstetrician gynecologist and Associate Professor Hyacinthe Zamané, serving at Yalgado Ouédraogo hospital, declared that the implementation of this new molecule is underway, hence the need to train health providers on its use and handling. According to Mr. Zamané, there was discussion of modifying and reviewing the protocol in order to introduce carbetocin in Burkina Faso. “We must develop a set of actions to effectively manage the hemorrhage. Hemorrhage does not warn and, when it occurs, it does not wait. We must act quickly to be able to manage it,” he noted.